In this issue of JAMA Oncology, two groups investigate the immune response to SARS-CoV-2, by proxy of antibody assays, in patients with solid malignant neoplasms who were undergoing active cancer therapy. With the concern that patients with cancer may not mount a robust protective immune response to SARS-CoV-2 infection or vaccination, the studies attempt to […]
This randomized controlled trial was to assess whether recommending surgical mask use outside the home reduces wearers’ risk for SARS-CoV-2 infection in a setting where masks were uncommon and not among recommended public health measures. The results from the study were published in the Annals of Internal Medicine.
This JAMA “Viewpoint” describes how to interpret two types of diagnostic tests commonly in use for SARS-CoV-2 infections—reverse transcriptase–polymerase chain reaction (RT-PCR) and IgM and IgG enzyme-linked immunosorbent assay (ELISA)—and how the results may vary over time.